NDA hosts 40th annual Pharmacovigilance centres' meeting
Uganda was the host of the 40th annual meeting of representatives of the National Pharmacovigilance Centres (NPC).The meeting was hosted by the National Drug Authority and held at Speke Resort Munyonyo, from 6th November to 10th November 2017. Uganda was chosen to host this meeting because of its remarkable progress in the safety of medicines in the African continent.May 6th - 10th 2018
Harvest money expo Nambole
NDA officers dispensing information to the public at the Harvest Money expo at NamboleFebruary 17th 2018
The Secretary to the Authority and Directors engage with journalists from various media houses
"We got some preliminary results from the tests we did on the suspected Hep B vaccines and so far all results are good but inconclusive. We're working with World Health Organization (WHO) to get the conclusive results," Victoria Nambasa - acting Director Product Safety.May 24th 2018
Pharmacovigilance training held in Hoima district.
World Health Organization (WHO) defines Pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. It is important to note that Uganda has a National Pharmacovigilance Center , under the National Drug Authority.
Updated List of Teratogenic Drugs (medicines with agents that can disturb the development of an embryo or fetus)
There are several teratogenic drugs which when used during pregnancy can disturb the development of the embryo or foetus by halting the pregnancy or producing congenital malformations (birth defects).
Follow this link to find a list of teratogenic drugs and our recommendation/s to pregnant mothers. Safe Drugs, Save Lives.
News and Announcements
Word from the director
The Product Safety directorate ensures that all stakeholders, pharmaceutical service providers and the general public receive the right information on medicines. The directorate also ensures that drug promotional materials are vetted, approved and monitored to ensure that misleading, biased and inaccurate information on medicines is not disseminated. It is also responsible for pharmacovigilance programs, adverse drug reactions reporting, clinical trials monitoring and hosting the National Pharmacovigilance Centre.
|Whatsapp 0791415555.||National Drug Authority|
|firstname.lastname@example.org||P. O Box 23096, Kampala, Uganda|
|email@example.com||Plot 19 Lumumba Avenue (opposite TWED plaza)|
|firstname.lastname@example.org||Tel: +256 417 788 100/1 +256 417 788 124 / 041 788 129|